Fidelity Disruptive Medicine ETF closed at $32.45 on Sep 28, up 0.75%, 1.3% below its 52-week closing high. Volume of 6.1K shares was 0.87× its 20-day average (close to normal).
Split-adjusted performance: -0.1% over one month, +37.3% over six months, +34.3% over one year.
Short interest was 4.1K shares at the Sep 15 settlement, down 36.9% from the prior report (1.0 days to cover).
No recent articles focused on Fidelity Disruptive Medicine ETF.
Quick answers
What is FMED's market cap?
$51.91M, based on the Sep 28 close of $32.45.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology